Cholinesterase Inhibitors & Organophosphate Poisoning
Take away the enzyme that mops up acetylcholine, and the transmitter floods every synapse at once. Handled in tiny, controlled amounts, this can lift a drooping myasthenic eyelid or sharpen a fading Alzheimer's memory. Unleashed by a pesticide or a nerve agent, the very same mechanism kills within minutes. This is the double life of the cholinesterase inhibitors — medicine and weapon separated only by dose.
A farmer is rushed into the emergency room, and the diagnosis is written all over his body: pinpoint pupils, streaming saliva and tears, soaked clothes, a chest full of fluid he's struggling to breathe through, a slow heart, and twitching muscles giving way to weakness. He was spraying organophosphate pesticide without protection. The poison has shut down his acetylcholinesterase, so acetylcholine is now drowning every synapse he has — muscarinic, nicotinic, and brain. Without the right antidotes in minutes, he will die of respiratory failure. Everything you need to save him comes from understanding one enzyme.
How they work: flooding the synapse indirectly
These are indirect agonists. Unlike the direct agonists, cholinesterase inhibitors don't touch the receptor at all. They block acetylcholinesterase, the enzyme that normally destroys acetylcholine in about a millisecond. With the cleanup crew disabled, acetylcholine accumulates and lingers, amplifying whatever the nerves are already releasing — at BOTH muscarinic and nicotinic sites. That's the key difference from a drug like pilocarpine: an indirect agonist only boosts existing cholinergic activity, but it boosts it everywhere at once.
The reversible inhibitors — the medicines
Reversible cholinesterase inhibitors bind the enzyme temporarily, and each has a home. Neostigmine doesn't enter the brain and is used to treat myasthenia gravis, to reverse surgical muscle paralysis, and to restart a sluggish gut or bladder. Pyridostigmine is the longer-acting cousin for day-to-day myasthenia gravis control. Edrophonium is ultra-short and historically used as a quick diagnostic test. Physostigmine DOES cross into the brain — which makes it the antidote for anticholinergic (atropine-type) poisoning. And a special group — donepezil, rivastigmine, galantamine — is designed to raise acetylcholine in the brain to slow the memory decline of Alzheimer's disease.
In myasthenia gravis, the immune system destroys nicotinic receptors at the neuromuscular junction, so muscles tire and weaken — classically a drooping eyelid that worsens through the day. There aren't enough working receptors, so the fix is to make each pulse of acetylcholine last longer and hit the survivors harder. Pyridostigmine does exactly that, and the eyelid lifts. It's the receptor map used as therapy.
- Cholinesterase inhibitors block ACh breakdown → ACh rises at muscarinic AND nicotinic sites.
- Neostigmine/pyridostigmine → myasthenia gravis & reversing muscle relaxants (no CNS entry).
- Physostigmine crosses into the brain → antidote for anticholinergic poisoning.
- Donepezil, rivastigmine, galantamine → Alzheimer's disease.
The irreversible inhibitors — the poisons
Organophosphates bind acetylcholinesterase almost permanently. They include agricultural insecticides (like malathion and parathion) and the chemical warfare nerve agents (sarin, VX). Worse, over minutes to hours the bond 'ages' into a truly irreversible lock, after which no antidote can free the enzyme. The result is a cholinergic crisis on every front at once: the muscarinic flood (the SLUDGE picture — pinpoint pupils, drowning secretions, bronchospasm, slow heart), the nicotinic overload (muscle twitching then paralysis), and central effects (confusion, seizures, coma). Death comes from respiratory failure — the airways fill with fluid, the bronchi clamp shut, and the breathing muscles are paralysed.
The antidote is a two-drug rescue, and knowing WHY each is given is the whole lesson. Atropine blocks the muscarinic receptors — it dries up the deadly secretions, opens the airways, and lifts the heart rate; it is the immediate life-saver, given repeatedly until the chest clears. But atropine does nothing for the nicotinic muscle paralysis. For that, pralidoxime (2-PAM) is given to physically pry the organophosphate off the enzyme and regenerate it — but ONLY if given before the bond has aged. Add airway support and a benzodiazepine for seizures, and you have the complete organophosphate antidote package.
Atropine treats the muscarinic signs; pralidoxime rescues the nicotinic ones. Remember it as: 'atropine dries the secretions, pralidoxime frees the enzyme.' Atropine buys survival by drying the airways, but only pralidoxime — given early, before aging — can reverse the muscle paralysis. Give atropine first and fast; give pralidoxime alongside and don't delay, because aging is a clock you can't stop.
- Giving only atropine in organophosphate poisoning. It won't fix the nicotinic muscle paralysis.
- Delaying pralidoxime. Once the enzyme 'ages,' pralidoxime can no longer reactivate it.
- Using physostigmine when you need a non-CNS drug (or vice versa). CNS penetration matters.
- Forgetting cholinesterase inhibitors hit nicotinic sites too — not just the muscarinic SLUDGE.
In organophosphate poisoning, why is pralidoxime added to atropine?
- Cholinesterase inhibitors raise acetylcholine everywhere by blocking its breakdown.
- Reversible ones treat myasthenia gravis, reverse muscle relaxants, and slow Alzheimer's.
- Organophosphates (pesticides, nerve agents) cause a lethal cholinergic crisis; the enzyme 'ages.'
- Antidote: atropine (muscarinic signs) + pralidoxime (reactivates enzyme, before aging) + support.
- Katzung BG. Basic & Clinical Pharmacology — Cholinesterase inhibitors & their clinical uses.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Anticholinesterase agents & organophosphate toxicity.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Cholinesterase inhibitors.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Anticholinesterases & organophosphate poisoning.
- WHO / clinical toxicology guidance — Organophosphate poisoning: atropine & pralidoxime.
